Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar-Apr;38(2):574-586.
doi: 10.21873/invivo.13476.

Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: Insight into Tumor Hypoxia

Affiliations

Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: Insight into Tumor Hypoxia

Zita Kepes et al. In Vivo. 2024 Mar-Apr.

Abstract

Background/aim: Herein we assessed the feasibility of imaging protocols using both hypoxia-specific [18F]F-FAZA and [18F]F-FDG in bypassing the limitations derived from the non-specific findings of [18F]F-FDG PET imaging of tumor-related hypoxia.

Materials and methods: CoCl2-generated hypoxia was induced in multidrug resistant (Pgp+) or sensitive (Pgp-) human ovarian (Pgp- A2780, Pgp+ A2780AD), and cervix carcinoma (Pgp- KB-3-1, Pgp+ KB-V-1) cell lines to establish corresponding tumor-bearing mouse models. Prior to [18F]F-FDG/[18F]F-FAZA-based MiniPET imaging, in vitro [18F]F-FDG uptake measurements and western blotting were used to verify the presence of hypoxia.

Results: Elevated GLUT-1, and hexokinase enzyme-II expression driven by CoCl2-induced activation of hypoxia-inducible factor-1α explains enhanced cellular [18F]F-FDG accumulation. No difference was observed in the [18F]F-FAZA accretion of Pgp+ and Pgp- tumors. Tumor-to-muscle ratios for [18F]F-FAZA measured at 110-120 min postinjection (6.2±0.1) provided the best contrasted images for the delineation of PET-oxic and PET-hypoxic intratumor regions. Although all tumors exhibited heterogenous uptake of both radiopharmaceuticals, greater differences for [18F]F-FAZA between the tracer avid and non-accumulating regions indicate its superiority over [18F]F-FDG. Spatial correlation between [18F]F-FGD and [18F]F-FAZA scans confirms that hypoxia mostly occurs in regions with highly active glucose metabolism.

Conclusion: The addition of [18F]F-FAZA PET to [18F]F-FGD imaging may add clinical value in determining hypoxic sub-regions.

Keywords: Cervix xenotransplants; GLUT-1 transporter; [18F]F-FAZA; [18F]F-FDG; hexokinase enzyme-II; hypoxia; hypoxia-inducible factor-1α (HIF-1α); ovarian xenotransplants; positron emission tomography (PET); preclinical.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest in relation to this study.

Figures

Figure 1
Figure 1. [18F]F-FDG uptake by KB-3-1 and A2780 cells. [18F]-Fluorodeoxyglucose; [18F]: Fluorine-18 ([18F]F-FDG) accumulation in KB-3-1 cells incubated with CoCl2 for 24 and 48 hs, and the radioactivity in control KB-3-1 cells (Panel A). The [18F]F-FDG uptake by KB-3-1 cells incubated for 24 h was significantly higher at all investigated time points compared both to the untreated control cells and to cells that were incubated for 48 h. The [18F]F-FDG uptake by A2780 cells administered with CoCl2 for 24 and 48 h and the radioactivity in the control A2780 cells (Panel B). The radioactivity in A2780 cells treated for 24 h was remarkably higher at the 30- and 60-min time points in comparison with the naïve control cells as well as cells administered with CoCl2 for 48 h. At the 15 min time point, the [18F]F-FDG accretion in the A2780 cells incubated for 24 h was considerably higher than the radioactivity in the untreated cells. *p≤0.05; **p≤0.01.
Figure 2
Figure 2. Western blot analyses of CoCl2-treated KB-3-1 and A2780 cells and their control counterparts. Expression levels of HIF-1α, HKII enzyme, and GLUT-1 transporter in CoCl2-incubated KB-3-1 (Panel A), and A2780 (Panel B) cells as well as in control KB-3-1 (Panel A) and A2780 (Panel B) cells.
Figure 3
Figure 3. Quantitative assessment of the [18F]F-fluoroazomycin arabinoside ([18F]F-FAZA) uptake by the investigated Pgp+ and Pgptumor xenografts. The standardized uptake value (SUV) (mean and max) values and the tumor-to-muscle (T/M) ratios (mean and max) of permeability glycoprotein (Pgp)- A2780 and KB-3-1 and Pgp+ A2780AD and KB-V-1 tumor xenografts for [18F]F-FAZA are demonstrated.
Figure 4
Figure 4. Temporal kinetics of Fluorine-18 F-fluoroazomycin arabinoside ([18F]F-FAZA) accumulation. The real-time temporal accumulation kinetics of the hypoxic tumor regions and the background (muscle) for [18F]F-FAZA are shown. SUV: Standardized uptake value.
Figure 5
Figure 5. Temporal kinetics of the Fluorine-18 fluoroazomycin arabinoside ([18F]F-FAZA) accumulation in the hypoxic and non-hypoxic regions of the investigated tumors. [18F]F-FAZA accumulation in a representative tumor xenograft (KB-3-1) at 20 min intervals from the start of the radiotracer injection (0 min) until the end point (140 min) of the dynamic acquisition (Panel A and C). Temporal uptake kinetics of [18F]F-FAZA in the hypoxic (red line) and non-hypoxic (black line) regions of the investigated tumors (Panel B). SUV: Standardized uptake value.
Figure 6
Figure 6. [18F]F-FDG and [18F]F-FAZA MiniPET examinations of SCID mice xenotransplanted with A2780, A2780AD, KB-3-1, and KBV-1 tumor cell lines. Representative coronal [18F]F-FDG and [18F]FFAZA positron emission tomography images of severe combined immunodeficient mice xenotransplanted with A2780, A2780AD, KB-3-1, and KB-V-1 tumor cell lines. Black arrows: Pgp negative tumors; red arrows: Pgp positive tumors. [18F]: Fluorine-18; [18F]F-FDG: [18F]Fluoro-2-deoxy-D-glucose; [18F]F-FAZA: [18F]F-fluoroazomycin arabinoside; SUV: standardized uptake value.
Figure 7
Figure 7. Quantitative evaluation of intratumor [18F]F-FDG and [18F]F-FAZA radiotracer uptake. Average SUVmean values of the intratumor areas with (+) or without (-) [18F]F-FDG/[18F]F-FAZA accumulation. **p≤0.01. [18F]: Fluorine-18; [18F]F-FDG: [18F]Fluoro-2-deoxy-D-glucose; [18F]F-FAZA: [18F]F-fluoroazomycin arabinoside; SUV: standardized uptake value.
Figure 8
Figure 8. Representative [18F]F-FDG and [18F]F-FAZA PET images of the hypoxic tumor regions. [18F]F-FDG and [18F]F-FAZA uptake patterns in the hypoxic tumor regions. The red arrows indicate the overlaps between the uptakes of the two radiopharmaceuticals. [18F]: Fluorine-18; [18F]F-FDG: [18F]Fluoro-2-deoxy-D-glucose; [18F]FFAZA: [18F]F-fluoroazomycin arabinoside; PET: positron emission tomography; SUV: standardized uptake value.

References

    1. Wigerup C, Påhlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152–169. doi: 10.1016/j.pharmthera.2016.04.009. - DOI - PubMed
    1. Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2(12):1117–1133. doi: 10.1177/1947601911423654. - DOI - PMC - PubMed
    1. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196. doi: 10.1038/nrm3758. - DOI - PMC - PubMed
    1. Zhang J, Zhang Y, Mo F, Patel G, Butterworth K, Shao C, Prise KM. The roles of HIF-1α in radiosensitivity and radiation-induced bystander effects under hypoxia. Front Cell Dev Biol. 2021;9:637454. doi: 10.3389/fcell.2021.637454. - DOI - PMC - PubMed
    1. Taylor PC, Sivakumar B. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol. 2005;17(3):293–298. doi: 10.1097/01.bor.0000155361.83990.5b. - DOI - PubMed